Search

Your search keyword '"Dignass, Axel"' showing total 18 results
Start Over Author "Dignass, Axel" Journal inflammatory bowel diseases
18 results on '"Dignass, Axel"'

1. Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.

Author

Sands, Bruce E, D'Haens, Geert, Clemow, David B, Irving, Peter M, Johns, Jordan T, Gibble, Theresa Hunter, Abreu, Maria T, Lee, Scott, Hisamatsu, Tadakazu, Kobayashi, Taku, Dubinsky, Marla C, Vermeire, Severine, Siegel, Corey A, Peyrin-Biroulet, Laurent, Moses, Richard E, Milata, Joe, Arora, Vipin, Panaccione, Remo, and Dignass, Axel

Published
2024
Full Text
View/download PDF

2. COMPARATIVE EFFICACY AND SAFETY OF SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS: AN INDIRECT COMPARISON FROM RANDOMIZED CONTROLLED TRIALS

Author

Sands, Bruce, primary, Peyrin-Biroulet, Laurent, additional, Schreiber, Stefan, additional, Danese, Silvio, additional, Armuzzi, Alessandro, additional, Buisson, Anthony, additional, Fumery, Mathurin, additional, Dignass, Axel, additional, Powell, Nick, additional, Kennedy, Nicholas, additional, Zeissig, Sebastian, additional, Kwon, Taek, additional, Kim, Seungmin, additional, Lee, Soohyun, additional, and Hanauer, Stephen, additional

Published
2024
Full Text
View/download PDF

4. Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus

Author

D’Amico, Ferdinando, primary, Magro, Fernando, additional, Siegmund, Britta, additional, Kobayashi, Taku, additional, Kotze, Paulo Gustavo, additional, Solitano, Virginia, additional, Caron, Benedicte, additional, Al Awadhi, Sameer, additional, Hart, Ailsa, additional, Jairath, Vipul, additional, Dignass, Axel, additional, Peyrin-Biroulet, Laurent, additional, and Danese, Silvio, additional

Published
2023
Full Text
View/download PDF

10. Erratum

Author

Paclik, Daniela, primary, Lohse, Katrin, additional, Wiedenmann, Bertram, additional, Dignass, Axel U., additional, and Sturm, Andreas, additional

Published
2011
Full Text
View/download PDF

11. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis†

Author

Baumgart, Daniel C., primary, Targan, Stephan R., additional, Dignass, Axel U., additional, Mayer, Lloyd, additional, Assche, Gert van, additional, Hommes, Daan W., additional, Hanauer, Stephen B., additional, Mahadevan, Uma, additional, Reinisch, Walter, additional, Plevy, Scott E., additional, Salzberg, Bruce A., additional, Buchman, Alan L., additional, Mechkov, Grigor M., additional, Krastev, Zahariy A., additional, Lowder, James N., additional, Frankel, Matthew B., additional, and Sandborn, William J., additional

Published
2010
Full Text
View/download PDF

13. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#

Author

Gasche, Christoph, primary, Berstad, Arnold, additional, Befrits, Ragnar, additional, Beglinger, Christoph, additional, Dignass, Axel, additional, Erichsen, Kari, additional, Gomollon, Fernando, additional, Hjortswang, Henrik, additional, Koutroubakis, Ioannis, additional, Kulnigg, Stefanie, additional, Oldenburg, Bas, additional, Rampton, David, additional, Schroeder, Oliver, additional, Stein, Jürgen, additional, Travis, Simon, additional, and Van Assche, Gert, additional

Published
2007
Full Text
View/download PDF

18. Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease.

Author

Sands BE, Danese S, Chapman JC, Gurjar K, Grieve S, Thakur D, Griffith J, Joshi N, Kligys K, and Dignass A

Abstract

Background: Healing in Crohn's disease is complex and difficult to measure due to incongruencies between clinical symptoms and disease states. Mucosal healing (MH) and transmural healing (TH) are increasingly used to measure clinical improvement in Crohn's disease, but definitions of MH and TH can vary across studies, and their relationship to long-term outcomes is not clear. To address this knowledge gap, we performed a systematic literature review (SLR) to examine studies measuring MH and TH in Crohn's disease., Methods: Database records from 2012 to 2022 were searched for real-world evidence and interventional studies that reported the association of MH or TH with clinical, economic, or quality of life outcomes of adult patients with Crohn's disease., Results: A total of 46 studies were identified in the systematic literature review, representing a combined patient population of 5530. Outcomes of patients with MH were reported by 39 studies; of these, 14 used validated scales for endoscopic assessment. Thirteen studies reported outcomes of patients with TH. Among studies that examined the outcomes of patients with and without MH or TH, patients with healing generally experienced improved clinical outcomes and reduced healthcare resource utilization, including fewer hospitalizations and surgeries and improved rates of clinical remission. This was especially true for patients with TH., Conclusions: Mucosal and transmural healing are associated with positive long-term outcomes for adult patients with Crohn's disease. The adoption of standardized measures and less invasive assessment tools will maximize the benefits of patient monitoring., (© 2024 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results